论文信息 - Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC) - 字舞流文

Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)

A. Wyatt | M. Lacouture | E. Antonarakis | W. Abida | D. Rathkopf | T. Curley | R. Aggarwal | J. Schonhoft | Heather H. Cheng | Karen E Knudsen | Daniel J George | Jimmy L Zhao | Elyn Riedel | Takayuki Sumiyoshi | Amanda Anderson | Ninghui Mao | Samuel Haywood | Brooke Decker | F. Feng | Brett S. Carver